報價延遲最少15分鐘:2025/12/20 07:29 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.78 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-139.72/0.08
|
|
企業價值
18.77M
|
| 資產負債 |
|
每股賬面淨值
-22.82
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
1.62M
|
|
每股收益
0.46
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment. |
